iPLEDGE REMS - Home The iPLEDGE REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure The REMS is required by the U S Food and Drug Administration (FDA) to ensure the benefits of isotretinoin outweigh its risks
Select Authentication System - iPLEDGE PROGRAM The iPLEDGE PROGRAM REMS (Risk Evaluation and Mitigation Strategy) The iPLEDGE PROGRAM REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure
Most Recent Update: MARCH 2023 - iPLEDGE PROGRAM The iPLEDGE REMS is a computer-based risk management system that uses verifiable, traceable links between prescriber, patient, pharmacy, and wholesaler to control prescribing, using, dispensing, and distribution of isotretinoin
McKesson - Secure File Transfer Web Client - Login This system is for the use of authorized users only Individuals using this computer system without authority, or in excess of their authority, are subject to having all of their activities on this system monitored and recorded by systems personnel In the, course of monitoring individuals improperly using this system, or in the course of system maintenance, the activities of authorized users